Spero Therapeutics, Inc. Common Stock (NASDAQ: SPRO) last traded at $1.22, up 0.83% on the session. The quote above updates while this page is open; the figures below are drawn from Spero Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Spero Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker SPRO. Its market capitalisation is $71.05 million.
Valuation measures for Spero Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $71.05M |
|---|---|
| Enterprise value | $28.83M |
| P/E ratio | 8.71 |
| Price / sales | 1.51 |
| Price / book | 1.61 |
| Beta | 1.47 |
Trailing-twelve-month figures tagged in Spero Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $47.00M |
|---|---|
| Net income (TTM) | $7.38M |
| EPS (TTM) | $0.140 |
| Operating margin | 12.82% |
| Return on equity | 16.70% |
| Cash | $50.77M |
Range and volume for SPRO over the past 52 weeks.
| 52-week high | $3.08 |
|---|---|
| 52-week low | $1.08 |
| Volume | 353.9K |
| Average volume | 1.59M |
| Previous close | $1.21 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.